{"id":"cggv:007697a5-2f83-40d0-b2ea-914e458a1452v2.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"cggv:007697a5-2f83-40d0-b2ea-914e458a1452_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10007","date":"2020-08-31T17:00:00.000Z","role":"Approver"},{"id":"cggv:007697a5-2f83-40d0-b2ea-914e458a1452_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10007","date":"2020-09-16T19:23:38.503Z","role":"Publisher"}],"evidence":[{"id":"cggv:007697a5-2f83-40d0-b2ea-914e458a1452_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:007697a5-2f83-40d0-b2ea-914e458a1452_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:b6029ed1-5ecb-48bf-8c7c-5341097087e4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:94fff316-95c1-4aaf-87a3-4e66b2ecbf17","type":"Finding","demonstrates":{"id":"cg:GeneExpressionA"},"dc:description":"RT-PCR and western blot analysis confirmed cochlear expression of MYH14, but they also found that the expression levels of MYH14 were dependent on noise exposure. Upgrading to 1 point for this experiment. In knockout mice, the levlels of MYH10 expression were even higher after noise exposure.","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/28101381","type":"dc:BibliographicResource","dc:abstract":"MYH14 is a member of the myosin family, which has been implicated in many motile processes such as ion-channel gating, organelle translocation, and the cytoskeleton rearrangement. Mutations in MYH14 lead to a DFNA4-type hearing impairment. Further evidence also shows that MYH14 is a candidate noise-induced hearing loss (NIHL) susceptible gene. However, the specific roles of MYH14 in auditory function and NIHL are not fully understood. In the present study, we used CRISPR/Cas9 technology to establish a Myh14 knockout mice line in CBA/CaJ background (now referred to as Myh14(-/-) mice) and clarify the role of MYH14 in the cochlea and NIHL. We found that Myh14(-/-) mice did not exhibit significant hearing loss until five months of age. In addition, Myh14(-/-) mice were more vulnerable to high intensity noise compared to control mice. More significant outer hair cell loss was observed in Myh14(-/-) mice than in wild type controls after acoustic trauma. Our findings suggest that Myh14 may play a beneficial role in the protection of the cochlea after acoustic overstimulation in CBA/CaJ mice.","dc:creator":"Fu X","dc:date":"2016","dc:title":"Loss of Myh14 Increases Susceptibility to Noise-Induced Hearing Loss in CBA/CaJ Mice."},"rdfs:label":"Cochlear expression of MYH14 in mice"}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"cggv:69c0e92f-5c72-4609-9619-7f26e8bc0ca7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:d8e86cc9-ee20-44c8-9d1b-bcab1ef5e2ab","type":"Finding","demonstrates":{"id":"cg:GeneExpressionA"},"dc:description":"RT-PCR of the Myh14 gene in mouse cochlea revealed high levels of expression.","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/15015131","type":"dc:BibliographicResource","dc:abstract":"Myosins have been implicated in various motile processes, including organelle translocation, ion-channel gating, and cytoskeleton reorganization. Different members of the myosin superfamily are responsible for syndromic and nonsyndromic hearing impairment in both humans and mice. MYH14 encodes one of the heavy chains of the class II nonmuscle myosins, and it is localized within the autosomal dominant hearing impairment (DFNA4) critical region. After demonstrating that MYH14 is highly expressed in mouse cochlea, we performed a mutational screening in a large series of 300 hearing-impaired patients from Italy, Spain, and Belgium and in a German kindred linked to DFNA4. This study allowed us to identify a nonsense and two missense mutations in large pedigrees, linked to DFNA4, as well as a de novo allele in a sporadic case. Absence of these mutations in healthy individuals was tested in 200 control individuals. These findings clearly demonstrate the role of MYH14 in causing autosomal dominant hearing loss and further confirm the crucial role of the myosin superfamily in auditive functions.","dc:creator":"Donaudy F","dc:date":"2004","dc:title":"Nonmuscle myosin heavy-chain gene MYH14 is expressed in cochlea and mutated in patients affected by autosomal dominant hearing impairment (DFNA4)."},"rdfs:label":"RT-PCR of MYH14 in Mouse Cochlea"}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"cggv:007697a5-2f83-40d0-b2ea-914e458a1452_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:6ddf155c-850f-4cb3-b3ca-f0b461851336","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:97249dd3-bb13-4d4d-a401-f5cacf107072","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"Used Auditory brainstem response to find that the auditory thresholds were increased in the MYH14 KO mice. Also did expression studies, (scored separately). Found that at 5 months of age MYH14 -/- mice have significant high frequency hearing loss relative to controls. They also found that these mice are less capable of recovering from noise damage, and that OHC loss was significantly increased 2 weeks after acoustic trauma in MYH14 -/- .","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28101381","rdfs:label":"MYH14 KO Mouse"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1,"dc:description":"Downgraded to one point because KO -/- is not consistent with inheritance pattern."}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"cggv:007697a5-2f83-40d0-b2ea-914e458a1452_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:007697a5-2f83-40d0-b2ea-914e458a1452_seg_el","type":"EvidenceLine","specifiedBy":"GeneValiditySegregationEvidencCriteria","strengthScore":1.8},{"id":"cggv:007697a5-2f83-40d0-b2ea-914e458a1452_ad_other_el","type":"EvidenceLine","evidence":[{"id":"cggv:f886243d-2a03-444d-8e69-59a398eafade_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:0569deae-7663-4031-814c-3f9b2267861f","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"40 exons amplified by PCR and sequenced","firstTestingMethod":"PCR","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"cggv:f886243d-2a03-444d-8e69-59a398eafade_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:41514e25-b857-4ebb-ad7a-277465957669","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001145809.1(MYH14):c.2299C>A (p.Arg767Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252135"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/15015131"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/15015131","rdfs:label":"Belgian Family Proband"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"cggv:3dee3bc0-48dd-4cca-89d3-06dfeb03a394_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:a1b9737b-815f-43a4-a9e0-61d547617594","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"detectionMethod":"Targeted resequencing of 80 deafness genes and then 129 gnees followed by variant filtering and the sanger sequencing.","firstTestingMethod":"Genotyping","phenotypeFreeText":"Father had prelingual hearing loss, mother had congenital hearing loss but from a different cause/variant than father.","phenotypes":["obo:HP_0000408","obo:HP_0000399","obo:HP_0008625"],"previousTesting":true,"previousTestingDescription":"Genetic testing of GJB2 as well as TRS-80, 129. Also, audiometry conducted at age 5. For more detail see family information","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:3dee3bc0-48dd-4cca-89d3-06dfeb03a394_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:b7471552-1b32-48ad-887f-49371d317b38","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000019.10:g.50223092A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406950445"}},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/28221712","type":"dc:BibliographicResource","dc:abstract":"Pathogenic variants of MYH14 are known to be associated (in either a syndromic or nonsyndromic manner) with hearing loss. Interestingly, all reported cases to date of MYH14-related nonsyndromic hearing loss with detailed phenotypes have demonstrated mild-to-moderate progressive hearing loss with postlingual onset.","dc:creator":"Kim BJ","dc:date":"2017","dc:title":"Discovery of MYH14 as an important and unique deafness gene causing prelingually severe autosomal dominant nonsyndromic hearing loss."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28221712","rdfs:label":"SH45-105"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"cggv:c706c437-7e49-4b26-8f0c-8a35304b6ea3_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:3a6a7c29-bab5-44fe-b32b-cc6576d56619","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"PCR amplification of the 40 coding exons of MYH14 followed by direct sequencing.","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"GJB2 common mutation screening, SNHL eval, normal tympanometric eval.","sex":"Male","variant":{"id":"cggv:c706c437-7e49-4b26-8f0c-8a35304b6ea3_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:f0df1569-fcdb-469d-9502-c9a367a0692c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001145809.1(MYH14):c.3049C>T (p.Leu1017Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252133"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/15015131"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/15015131","rdfs:label":"Italian Family III:2"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.25,"dc:description":"Only one segregation as evidence. Would not score if the variant wasn't essentially absent from gnomAD, 1/230852 alleles."},{"id":"cggv:3d12cfa2-6a8e-462e-91e5-187d7b52a4b9_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:2cc2854f-838e-4e0a-af3d-1c6569b6a7d8","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"Analysis of the 40 exons and exon-intro boundaries of MYH14, including RFLP analysis.","firstTestingMethod":"PCR","phenotypeFreeText":"high frequency hearing loss","previousTesting":true,"previousTestingDescription":"previous diagnosis of ADNSHL","sex":"Male","variant":{"id":"cggv:3d12cfa2-6a8e-462e-91e5-187d7b52a4b9_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:b36fa230-fd84-4fc2-8d22-6c3a7f29d031","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000019.10:g.50301793G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406964925"}},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/27393652","type":"dc:BibliographicResource","dc:abstract":"Myosin is a key protein involved in regulating the shape and motility of cells. The MYH9 and MYH14 genes, which encode non-muscle myosin heavy chain IIA (NMMHC II-A) and IIC (NMMHC II-C), respectively, are expressed in the inner ear. These myosin genes are known to be associated with autosomal dominant non-syndromic hearing loss (ADNSHL); however, genetic studies in patients with ADNSHL in Korea have rarely been reported.","dc:creator":"Kim SJ","dc:date":"2016","dc:title":"Genetic association of MYH genes with hereditary hearing loss in Korea."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/27393652","rdfs:label":"III-1"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"cggv:7789f508-e35e-44ab-9850-8604d197bb72_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:5cb5616b-8a35-4999-9207-8872f88fc2e0","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"WES","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"left foot inversion","phenotypes":["obo:HP_0000365","obo:HP_0001263"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"cggv:7789f508-e35e-44ab-9850-8604d197bb72_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:761c51b0-8f53-4af0-a983-f7c6c1d3c38d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001145809.2(MYH14):c.2971G>A (p.Glu991Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA309561876"}},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/30828794","type":"dc:BibliographicResource","dc:abstract":"","dc:creator":"Truong BT","dc:date":"2019","dc:title":"Exome sequencing reveals novel variants and unique allelic spectrum for hearing impairment in Filipino cochlear implantees."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30828794","rdfs:label":"26"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0,"dc:description":"No supporting functional evidence nor progressive HL"},{"id":"cggv:747df908-eead-4987-84c4-15fee479d3e5_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:c5924b33-35f1-429c-9e5b-35e91cba973a","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":41,"detectionMethod":"WES","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"asymmetric progressive HL","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"cggv:747df908-eead-4987-84c4-15fee479d3e5_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:07afcbb8-cfa8-4b46-9ccb-555efbca3cb7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001145809.2(MYH14):c.3068C>T (p.Ala1023Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9593104"}},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/31045651","type":"dc:BibliographicResource","dc:abstract":"Late-onset, down-sloping sensorineural hearing loss has many genetic and nongenetic etiologies, but the proportion of this commonly encountered type of hearing loss attributable to genetic causes is not well known. In this study, the authors performed genetic analysis using next-generation sequencing techniques in patients showing late-onset, down-sloping sensorineural hearing loss with preserved low-frequency hearing, and investigated the clinical implications of the variants identified.","dc:creator":"Song MH","dc:date":"2020","dc:title":"Genetic Inheritance of Late-Onset, Down-Sloping Hearing Loss and Its Implications for Auditory Rehabilitation."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/31045651","rdfs:label":"YUHL 77-21"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0,"dc:description":"Variant pathogenicity not supported by functional evidence. Allele frequency inconsistent with dominant inheritance pattern."},{"id":"cggv:90808301-25e5-43be-a5b5-77941a63e724_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:f23d4c2a-abf6-4b47-aa84-2d24359aad94","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"Screening of all 40 coding exons of MYH14, in a ddition the BCL2l12, CKAP1 ACTN4, ATF5 TRPM4 HRC AND SBBI54 genes were sequenced as they are seven other cochlear expressed genes in the critical interval of DNFA4.Following the identification of the variants, the frequency of allele variants in the family was identified via DHPLC.","firstTestingMethod":"PCR","phenotypeFreeText":"moderate hearing loss across frequencies.","phenotypes":"obo:HP_0008504","previousTesting":true,"previousTestingDescription":"threshold audiograms were obtained after otoscopic examination\nby pure-tone audiometry in a sound-treated room according\nto current clinical standards. On consenting persons,\nvenous blood samples were obtained for DNA extraction. The\nInstitutional Review Boards of the University of TuÂ¨ bingen and\nthe University of Iowa approved all procedures. One individual was sequenced for mutations and then all affected individuals were screened for the S120L variant.","secondTestingMethod":"High resolution melting","sex":"UnknownEthnicity","variant":{"id":"cggv:90808301-25e5-43be-a5b5-77941a63e724_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:996d7e5d-d30b-4d90-9f60-4f18babd7653","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_024729.3(MYH14):c.359C>T (p.Ser120Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252137"}},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/16222661","type":"dc:BibliographicResource","dc:abstract":"Mutations in the heavy chain of the class II nonmuscle myosin, MYH14, cause autosomal dominant hearing loss in families linked to the DFNA4 locus. Consistent with this discovery, we identified an S120L mutation in MYH14 in a large German family segregating deafness that links to DFNA4. However, complete screening of the American family that originally defined the DFNA4 locus revealed no mutations in this gene. Furthermore, haplotyping of a single nucleotide polymorphism (SNP) 5' to MYH14 excludes this gene from the critical region in this family. Our results imply that mutations in another gene result in deafness at the DFNA4 locus. The newly defined candidate region encompasses a region of approximately 19 cM. Several candidate genes have been screened for disease-causing mutations.","dc:creator":"Yang T","dc:date":"2005","dc:title":"Genetic heterogeneity of deafness phenotypes linked to DFNA4."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/16222661","rdfs:label":"TL-01"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":2.25},{"id":"cggv:007697a5-2f83-40d0-b2ea-914e458a1452_ad_null_el","type":"EvidenceLine","evidence":[{"id":"cggv:fb3280ee-b3f8-41a6-afca-6a308602813f_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:8b3fad95-cbc4-4cbc-9943-80e8bfdb86dd","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"Linkage analysis mapped to 2.7Mb region for DFNA4 locus containig MYH14. 40 exons and splice sites amplified by PCR and sequenced directly.","firstTestingMethod":"Genotyping","phenotypeFreeText":"progressive sensorineural hearing impairment that starts in the 1st or 2nd decade of life and leads to severe-to-profound hearing loss in the 4th decade of life.","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"cggv:fb3280ee-b3f8-41a6-afca-6a308602813f_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:1690b72b-1c46-439d-b20e-61c2f125a125","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001145809.1(MYH14):c.20C>A (p.Ser7Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252130"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/15015131"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/15015131","rdfs:label":"Tu-N Proband"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"cggv:9c7e6349-3856-4b9d-8fe3-b06126d7c1be_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:51792b1a-ad9e-4aa0-8da4-1137baff4f7d","type":"Proband","ageType":"AgeAtReport","ageUnit":"Months","ageValue":7,"detectionMethod":"Targeted panel of deafness genes (80) followed by candidate variant segregation filtering and Sanger confirmation in affected family members.","firstTestingMethod":"Genotyping","phenotypes":["obo:HP_0008625","obo:HP_0000399","obo:HP_0000408"],"previousTesting":true,"previousTestingDescription":"pure tone audiometry","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:9c7e6349-3856-4b9d-8fe3-b06126d7c1be_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:e69cad35-f6fb-43cb-8c51-f2696bb2d563","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000019.10:g.50210438C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406945720"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28221712"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28221712","rdfs:label":"SH165-364"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":3},{"id":"cggv:007697a5-2f83-40d0-b2ea-914e458a1452_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"cggv:28845bdc-fea8-471d-8898-c493a107afaa_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:eb643b78-1b0a-4ed7-b75e-f3561e9f4894","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"detectionMethod":"Whole exome sequencing narrowed down the causitive mutation to either an AR compound heterozygous mutation in HOXC6, LOC100132247, NBPF9 SLX4     OR a de novo missense mutation in MYH14. After segregation analysis it was concluded that the cause of the hearing impairment in this individual was the de novo AD mutation in MYH14.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"mild to moderate SNHL","previousTesting":true,"previousTestingDescription":"Clinical evaluation of ENT as well as pure-tone audiometry","sex":"Female","variant":{"id":"cggv:28845bdc-fea8-471d-8898-c493a107afaa_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:11e6591e-837c-4bc5-8981-1b3fbfb8364b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000019.10:g.50249776G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406959800"}},"alleleOrigin":{"id":"obo:GENO_0000880"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/25719458","type":"dc:BibliographicResource","dc:abstract":"This study was designed to delineate genetic contributions, if any, to sporadic forms of mild to moderate sensorineural hearing loss (SNHL) not related to GJB2 mutations (DFNB1) in a pediatric population.","dc:creator":"Kim NK","dc:date":"2015","dc:title":"Whole-exome sequencing reveals diverse modes of inheritance in sporadic mild to moderate sensorineural hearing loss in a pediatric population."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25719458","rdfs:label":"SB119-211"}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":1,"dc:description":"EP decided 2 points for de novo was too high, only 1 point."},{"id":"cggv:28f0f01f-886c-4cc8-b7a3-f5e39e7568a6_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:99f04289-abb4-4cf0-8830-0fd811c2bfc4","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":58,"detectionMethod":"WES","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"progressive down-sloping HL","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"cggv:28f0f01f-886c-4cc8-b7a3-f5e39e7568a6_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:9a35d374-05fd-47a5-ba65-4bb15dc1e55f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001145809.2(MYH14):c.2692A>C (p.Lys898Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9593031"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/31045651"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/31045651","rdfs:label":"YUHL 83-21"}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":0,"dc:description":"Variant presumed de novo based on negative family history. No functional evidence is available to support pathogenicity of variant and allele frequency is inconsistent with dominant inheritance pattern."},{"id":"cggv:e10036a8-a502-452e-b31c-57bd87a1544b_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:670e78bc-1754-4900-86f2-98fd4d931977","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"detectionMethod":"40 primer pairs were used to amplify the 40 coding exons of MYH14 gene including the splice sites. Direct sequencing was then performed. Sequencing of this individuals parents also confirmed the de novo varaint.","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"one of 300 subjects analyzed for MYH14 mutations. Previously tested for most common mutations within the GJB2 gene, sensorineural hearing loss, and normal tympanometric evaluation. Physical examination, otoscopy, pure tone audiometry","sex":"Male","variant":{"id":"cggv:e10036a8-a502-452e-b31c-57bd87a1544b_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:62a2fe9a-fe91-4764-bb52-174f6df36b60","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001145809.1(MYH14):c.1150G>T (p.Gly384Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA133457"}},"alleleOrigin":{"id":"obo:GENO_0000880"},"paternityMaternityConfirmed":"No","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15015131"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/15015131","rdfs:label":"Donaudy_1 de novo"}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":0.5,"dc:description":"This variant is de novo, however, it was detected in 5 homozygotes in gnomAD and since only candidate gene sequencing was done, this variant has less of a chance of being the causative mutation."},{"id":"cggv:fead5d09-1a46-4d42-aae9-b60415c84e39_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Inconclusive","evidence":[{"id":"cggv:8bc960b4-e0b7-4a70-88be-e59662e90589","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"Exome sequencing confirmed variants by Sanger.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Individuals with the c.541G>A mutation had U shape hearing loss in the first decade of life","previousTesting":true,"previousTestingDescription":"clinical evaluation and diagnosis of hearing loss","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:fead5d09-1a46-4d42-aae9-b60415c84e39_variant_evidence_item","type":"MolecularSequenceObservation","allele":[{"id":"cggv:098f64f5-68c3-4c6b-9a55-d52e608d4916","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000019.10:g.50217750G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406948099"}},{"id":"cggv:cb57c636-a51d-4348-8181-3f43c2e314c1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000019.10:g.50266899C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA406947542"}}],"alleleOrigin":{"id":"obo:GENO_0000880"},"paternityMaternityConfirmed":"No","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/25289672","type":"dc:BibliographicResource","dc:abstract":"Inherited deafness has been shown to have high genetic heterogeneity. For many decades, linkage analysis and candidate gene approaches have been the main tools to elucidate the genetics of hearing loss. However, this associated study design is costly, time-consuming, and unsuitable for small families. This is mainly due to the inadequate numbers of available affected individuals, locus heterogeneity, and assortative mating. Exome sequencing has now become technically feasible and a cost-effective method for detection of disease variants underlying Mendelian disorders due to the recent advances in next-generation sequencing (NGS) technologies. In the present study, we have combined both the Deafness Gene Mutation Detection Array and exome sequencing to identify deafness causative variants in a large Chinese composite family with deaf by deaf mating. The simultaneous screening of the 9 common deafness mutations using the allele-specific PCR based universal array, resulted in the identification of the 1555A>G in the mitochondrial DNA (mtDNA) 12S rRNA in affected individuals in one branch of the family. We then subjected the mutation-negative cases to exome sequencing and identified novel causative variants in the MYH14 and WFS1 genes. This report confirms the effective use of a NGS technique to detect pathogenic mutations in affected individuals who were not candidates for classical genetic studies.","dc:creator":"Qing J","dc:date":"2014","dc:title":"Whole-exome sequencing to decipher the genetic heterogeneity of hearing loss in a Chinese family with deaf by deaf mating."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25289672","rdfs:label":"IIIB:1"}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":0.5,"dc:description":"Did not score this because there are several causes of HL in this family including this de novo variant p.T865M and therefore it is not convincing evidence that it is causing the hearing loss. The other missense variant p.A181T does segregate with HL, so these variants were essentially scored as one missense variant with evidence."}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":8.55}],"evidenceStrength":"Moderate","sequence":1139,"specifiedBy":"GeneValidityCriteria7","strengthScore":10.55,"subject":{"id":"cggv:280cc78c-cb8d-4601-a941-5061e123c189","type":"GeneValidityProposition","disease":"obo:MONDO_0019497","gene":"hgnc:23212","modeOfInheritance":"obo:HP_0000006"},"version":"2.0","dc:description":"The relationship between MYH14 and autosomal dominant nonsyndromic genetic deafness was described in 2004 by Donaudy et al. (PMID:15015131). At least 14 unique variants (missense, nonsense) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level, segregation, and experimental data. MYH14 is thought to play a beneficial role in the protection of the cochlea after acoustic over-stimulation and that loss of function leads to progressive hearing loss (PMID: 28101381). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Hearing Loss Working Group on 8/31/2020. Of note, MYH14 has also been associated with a neuropathy phenotype that includes hearing loss, but that evidence was not included in this curation.\n","dc:isVersionOf":{"id":"cggv:007697a5-2f83-40d0-b2ea-914e458a1452"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}